Andrew Hack

Andrew Hack

Director/Board Member chez NUVALENT, INC.

Fortune : 197 773 $ au 31/03/2024

50 ans
Health Technology
Finance
Consumer Services

Profil

Andrew A.
F.
Hack
founded Reify Corp.
in 2002, where he worked as Director-Life Sciences from 2002 to 2004.
Dr. Hack also currently works at Mersana Therapeutics, Inc., as Independent Director from 2017, JenaValve Technology, Inc., as Director, Affinivax, Inc., as Director, Imperative Care, Inc., as Director, Nuvalent, Inc., as Independent Director from 2021, and Bain Capital Life Sciences LP, as Partner from 2019.
Dr. Hack also formerly worked at Life Sciences, Inc., as Director from 2002 to 2004, Dynavax Technologies Corp., as Independent Director from 2021 to 2023, Atea Pharmaceuticals, Inc., as Independent Director from 2020 to 2021, Allena Pharmaceuticals, Inc., as Independent Director from 2018 to 2021, Xilio Therapeutics, Inc., as Director in 2021, BCLS Acquisition Corp., as Chief Financial Officer & Director, MPM BioEquities Adviser LLC, as Analyst from 2006 to 2007, HealthCor Management LP, as Analyst from 2009 to 2011, MPM BioImpact, Inc, as Principal from 2006 to 2007, Millennium Management LLC, as Portfolio Manager from 2011 to 2015, Carlyle-Blue Wave Partners, as Analyst from 2007 to 2008, and Editas Medicine, Inc., as Chief Financial & Accounting Officer from 2015 to 2019.
Dr. Hack received his undergraduate degree, graduate degree, and doctorate degree from The University of Chicago.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/06/2023 10 714 ( 0,01% ) 132 961 $ 31/03/2024
08/06/2023 14 467 ( 0,01% ) 64 812 $ 31/03/2024
15/06/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Andrew Hack

SociétésPosteDébut
MERSANA THERAPEUTICS, INC. Director/Board Member 06/01/2017
NUVALENT, INC. Director/Board Member 11/05/2021
Director/Board Member -
Director/Board Member -
Director/Board Member -
Private Equity Investor 01/03/2019
Tous les postes actifs de Andrew Hack

Anciens postes connus de Andrew Hack

SociétésPosteFin
DYNAVAX TECHNOLOGIES CORPORATION Chairman 19/10/2021
XILIO THERAPEUTICS, INC. Director/Board Member 01/10/2021
ATEA PHARMACEUTICALS, INC. Director/Board Member 18/06/2021
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Andrew Hack

Formation de Andrew Hack

The University of Chicago Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Andrew Hack

Relations

94

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées7
DYNAVAX TECHNOLOGIES CORPORATION

Health Technology

MERSANA THERAPEUTICS, INC.

Health Technology

ATEA PHARMACEUTICALS, INC.

Health Technology

EDITAS MEDICINE, INC.

Health Technology

XILIO THERAPEUTICS, INC.

Health Technology

NUVALENT, INC.

Health Technology

ALLENA PHARMACEUTICALS, INC.

Health Technology

Entreprise privées12

Health Technology

Finance

Finance

Finance

Finance

Finance

Health Technology

Health Technology

Finance

Technology Services

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Andrew Hack